Recombinant Human TWSG1, N-His

Description of Recombinant Human TWSG1, N-His

Introduction to Recombinant Human TWSG1

Recombinant Human TWSG1, also known as Transforming Growth Factor Beta-Induced Factor (TGIF), is a protein that plays a crucial role in various biological processes such as cell proliferation, differentiation, and development. This protein is a member of the transforming growth factor beta (TGF-β) superfamily, which includes a diverse group of proteins involved in regulating cellular functions.

Structure of Recombinant Human TWSG1

Recombinant Human TWSG1 is a homodimeric protein, meaning it is composed of two identical subunits. Each subunit is made up of 191 amino acids and has a molecular weight of approximately 21 kDa. The protein contains a conserved cysteine knot structure, which is a characteristic feature of the TGF-β superfamily. This structure is essential for the biological activity of TWSG1.

Activity of Recombinant Human TWSG1

Recombinant Human TWSG1 is a multifunctional protein that has been shown to have both pro- and anti-tumorigenic effects. It is primarily known for its ability to inhibit cell proliferation and induce cell differentiation, making it a potential therapeutic target for cancer treatment. TWSG1 has also been found to play a role in embryonic development, wound healing, and immune regulation.

One of the main mechanisms of action of TWSG1 is through its interaction with TGF-β receptors. TWSG1 can bind to both type I and type II TGF-β receptors, leading to the activation of downstream signaling pathways. This results in the inhibition of cell growth and induction of cell differentiation. TWSG1 has also been shown to modulate the activity of other signaling pathways, including the Wnt and Notch pathways, which are involved in cell fate determination and proliferation.

Application of Recombinant Human TWSG1

Recombinant Human TWSG1 has a wide range of potential applications in both basic research and clinical settings. One of the main applications of TWSG1 is in cancer therapy. Studies have shown that TWSG1 can inhibit the growth of various cancer cell lines, including breast, lung, and colon cancer. Additionally, TWSG1 has been found to sensitize cancer cells to chemotherapy, making it a potential adjuvant therapy for cancer treatment.

In addition to cancer, TWSG1 has also been investigated for its potential role in other diseases. For instance, TWSG1 has been shown to promote wound healing by stimulating the migration and proliferation of skin cells. It has also been implicated in the regulation of immune responses, making it a potential therapeutic target for autoimmune diseases.

Moreover, recombinant TWSG1 has been used in various in vitro and in vivo studies as a tool to investigate its biological functions. The availability of recombinant TWSG1 has allowed researchers to study its effects on different cell types and tissues, providing valuable insights into its role in various physiological and pathological processes.

Conclusion

In summary, Recombinant Human TWSG1 is a multifunctional protein with diverse biological activities. Its structure, activity, and potential applications make it a promising target for cancer therapy and other diseases. The availability of recombinant TWSG1 has greatly facilitated its study and has the potential to lead to the development of novel treatments for various diseases. Further research on TWSG1 is essential to fully understand its role in different biological processes and to explore its therapeutic potential.